Salem Investment Counselors’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-21,806
Closed -$15.3K 1216
2024
Q1
$15.3K Buy
21,806
+15,666
+255% +$17.7K ﹤0.01% 763
2023
Q4
$10.7K Hold
6,140
﹤0.01% 804
2023
Q3
$8.84K Hold
6,140
﹤0.01% 813
2023
Q2
$16K Hold
6,140
﹤0.01% 740
2023
Q1
$22.6K Hold
6,140
﹤0.01% 672
2022
Q4
$10.9K Sell
6,140
-100
-2% -$266 ﹤0.01% 764
2022
Q3
$25K Hold
6,240
﹤0.01% 605
2022
Q2
$35K Hold
6,240
﹤0.01% 568
2022
Q1
$92K Hold
6,240
﹤0.01% 424
2021
Q4
$99K Buy
6,240
+2,140
+52% +$51.4K ﹤0.01% 451
2021
Q3
$132K Sell
4,100
-2,000
-33% -$70.3K 0.01% 389
2021
Q2
$254K Buy
6,100
+100
+2% +$4.11K 0.01% 300
2021
Q1
$305K Sell
6,000
-13,000
-68% -$680K 0.02% 249
2020
Q4
$616K Buy
+19,000
New +$269K 0.04% 184

Other funds holding DMTK

Salem Investment Counselors's DMTK Position: Q2 2024 in Review

Salem Investment Counselors sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 21,806 shares — an estimated $15.3K sold.

Salem Investment Counselors first reported a position in DMTK in Q4 2020 and held it in 14 quarters. The position peaked at $616K in Q4 2020. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • Salem Investment Counselors reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Salem Investment Counselors sold 21,806 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $15.3K.
  • Salem Investment Counselors first reported a position in DermTech, Inc. Common Stock in Q4 2020 and held it in 14 quarters.
  • Salem Investment Counselors's DermTech, Inc. Common Stock position peaked at $616K in Q4 2020.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Salem Investment Counselors's 13F filing for Q2 2024, filed 11 Jul 2024.